Wettig Thane bought FGEN
January 9, 2025 · Form 4 insider transaction
Wettig Thane bought 1,300,000 shares of FibroGen Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,300,000
Price
$0.00
Total value
N/A
InsiderWettig Thane
RoleOfficer, Director
CompanyFibroGen Incorporated (FGEN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2025
Filing dateJanuary 10, 2025
Shares owned after1,300,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in equal amount quarterly over 4 years measured from 1/9/2025.